Synthesis of Stable Cholesteryl-Polyethylene Glycol-Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths. 2020

Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
Department of Surfactants and Nanobiotechnology, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

A method for conjugating cholesterol to peptide ligands through non-disperse polyethylene glycol (ND-PEG) through a non-hydrolysable linkage is described. The iterative addition of tetraethylene glycol macrocyclic sulfate to cholesterol (Chol) renders a family of highly pure well-defined Chol-PEG compounds with different PEG lengths from 4 up to 20 ethylene oxide units, stably linked through an ether bond. The conjugation of these Chol-PEG compounds to the cyclic (RGDfK) peptide though Lys5 side chains generates different lengths of Chol-PEG-RGD conjugates that retain the oligomer purity of the precursors, as analysis by HRMS and NMR has shown. Other derivatives were synthesized with similar results, such as Chol-PEG-OCH3 and Chol-PEG conjugated to glutathione and Tf1 peptides through maleimide-thiol chemoselective ligation. This method allows the systematic synthesis of highly pure uniform stable Chol-PEGs, circumventing the use of activation groups on each elongation step and thus reducing the number of synthesis steps.

UI MeSH Term Description Entries

Related Publications

Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
September 2006, Bioorganic & medicinal chemistry,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
January 2003, Biomacromolecules,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
November 1994, Nucleic acids research,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
November 2021, Journal of controlled release : official journal of the Controlled Release Society,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
October 2016, European journal of medicinal chemistry,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
May 2017, Biotechnology journal,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
December 1984, FEBS letters,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
October 2008, Cancer biotherapy & radiopharmaceuticals,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
February 2004, Bioorganic & medicinal chemistry letters,
Edgar Cristóbal-Lecina, and Daniel Pulido, and Pau Martin-Malpartida, and Maria J Macias, and Fernando Albericio, and Miriam Royo
December 2016, Artificial cells, nanomedicine, and biotechnology,
Copied contents to your clipboard!